Corcept Therapeutics (NASDAQ:CORT) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-24. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Corcept Therapeutics will report an earnings per share (EPS) of $0.31.

The market awaits Corcept Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Earnings Track Record

In the previous earnings release, the company beat EPS by $0.01, leading to a 7.81% increase in the share price the following trading session.

Here's a look at Corcept Therapeutics's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	0.15	0.20	0.14	0.37
EPS Actual	0.16	0.29	0.17	0.26
Price Change %	8.00	3.00	-4.00	-6.00

Tracking Corcept Therapeutics's Stock Performance

Shares of Corcept Therapeutics were trading at $34.82 as of February 20. Over the last 52-week period, shares are down 42.17%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

Insights Shared by Analysts on Corcept Therapeutics

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Corcept Therapeutics.

Analysts have given Corcept Therapeutics a total of ratings, with the consensus rating being . The average one-year price target is $, indicating a potential .

To track all earnings releases for Corcept Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.